United States · FDA National Drug Code directory
NUVAXOVID 2026-27
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49281-026_7c54fe54-5938-4350-b3e9-08878951bedc
- Product NDC
- 49281-026
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- NVX-COV2928
- Labeler
- Sanofi Vaccines US Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260827
- Source listing expiry
- 20271231
Source-listed ingredients
- NVX-COV2928 — 5 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (49281-026-50) / .5 mL in 1 SYRINGE (49281-026-88) · 49281-026-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →